Rybrevant OverviewAmivantamab, sold under the brand name Rybrevant, is a monoclonal antibody medication used to treat non-small cell lung cancer. The most common side effects include rash, infusion-related reactions, skin infections around the fingernails or toenails, muscle and joint pain, shortness of breath, nausea, fatigue, swelling in the lower legs or hands or face, sores in the mouth, cough, constipation, vomiting and changes in certain blood test...
Read more Rybrevant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Amivantamab
Recent Rybrevant Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 350mg/7ml(50mg/ml)
NDC Database Records for Rybrevant: (1 result)Sorted by National Drug Code
- 57894-501 Rybrevant 350 mg Intravenous Injection by Janssen Biotech, Inc.